Dear reader of ADxS.org, please excuse the disruption.

ADxS.org needs around €58,500 in 2024. Unfortunately 99,8 % of our readers do not donate. If everyone reading this appeal made a small contribution, our fundraising campaign for 2024 would be over after a few days. This appeal is displayed 23,000 times a week, but only 75 people donate. If you find ADxS.org useful, please take a minute to support ADxS.org with your donation. Thank you very much!

Since 01.06.2021 ADxS.org is supported by the non-profit ADxS e.V. Donations to ADxS e.V. are tax-deductible in Germany (up to €300, the remittance slip is sufficient as a donation receipt).

If you would prefer to make an active contribution, you can find ideas for Participation or active support here.

$45213 of $63500 - as of 2024-10-31
71%
ADxS.org Logo
ADxS.org Logo
Search Donations Addresses Recent changes ADHS-Forum Deutsche Version
Register

Already have an account? Login

Header Image
Moclobemide for ADHD

Sitemap

The ADxS.org project
Abstract from ADxS.org
Symptoms
Consequences of ADHD
Origin
Stress
Neurological aspects
Diagnostics
Prevention
Treatment: Guide and Effect size
Treatment: Medication for ADHD
Treatment: Medication for ADHD - Overview
Choice of medication for ADHD or ADHD with comorbidity
Dosing of medication for ADHD
Suitable medication for ADHD
Experimental medication for ADHD
Sleep disorder-related medication for ADHD
Appetite-enhancing medication for ADHD
Medication for ADHD in development
Less suitable medication for ADHD
Vitamins, minerals, dietary supplements for ADHD
Plant extracts for ADHD
Medication and drugs - the difference
Substance abuse with self-medication effect in ADHD
Non-drug treatment
Addresses
This and that about ADHD
Tests and surveys
Forum

Moclobemide for ADHD

Previous page Next page

Moclobemide is a reversible MAO-A and MAO-B inhibitor1 and consequently inhibits the metabolization of serotonin and noradrenaline, so that serotonin and noradrenaline are broken down more slowly and are therefore available for longer.

Due to its reversibility, no diet is required.

There are only a very small number of sources on moclobemide for ADHD.

  • Since 2000, PubMed has found only one study under Moclobemide and ADHD that addresses the treatment of comorbid opiate addiction and ADHD.2
  • Häßler reports a good effect on the ADHD symptoms of hyperactivity and frustration intolerance.3

High side effects at the beginning.
Gradually phase out when discontinuing.

Moclobemide is only likely to be useful in a few specific cases of ADHD.

  1. Edel, Vollmoeller (2006): Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, Seite 45 ↥

  2. Vaiva De Lenclave; Bailly (2002): Treatment of comorbid opiate addiction and attention-deficit hyperactivity disorder (residual type) with moclobemide: a case report; Prog Neuropsychopharmacol Biol Psychiatry. 2002 Apr;26(3):609-11. ↥

  3. Häßler (2009): substanzgebundene Alternativen in der Therapie von ADHS, Seite 175, in: Häßler (Hrsg) das ADHS Kaleidoskop – State of the Art und bisher nicht beachtete Aspekte von hoher Relevanz; medizinisch wissenschaftliche Verlagsgesellschaft ↥

Diese Seite wurde am 18.03.2024 zuletzt aktualisiert.
Previous page Next page